S 1954 · 119th CongressIn Committeecongress.gov ↗

Biosimilar Red Tape Elimination Act

What this bill does

AI plain-language summary

This bill appears to deal with reducing rules or requirements related to biosimilars, which are medicines made to work very similarly to existing brand-name biological drugs. No official summary is available for this bill.

Introduced

June 4, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.